DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$9.99−0.28 (-2.73%)
Close on Nov 17, 2026Market cap $628.15MP/E –Yield –
DBV Technologies shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
DBV Technologies's shares outstanding was 451M at Sep 30, 2026. For fiscal 2025 it was 140M, up 43.9% from the year before. Over ten years it grew 20.6% a year on average. The highest annual figure on record is 28.92B in fiscal 2018.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 140M | +43.9% |
| FY2024 | Dec 31, 2024 | 97M | +2.0% |
| FY2023 | Dec 31, 2023 | 95M | +22.9% |
| FY2022 | Dec 31, 2022 | 77M | +40.9% |
| FY2021 | Dec 31, 2021 | 55M | +1.5% |
| FY2020 | Dec 31, 2020 | 54M | +46.2% |
| FY2019 | Dec 31, 2019 | 37M | -99.9% |
| FY2018 | Dec 31, 2018 | 28.92B | +16.8% |
| FY2017 | Dec 31, 2017 | 24.76B | +101136.3% |
| FY2016 | Dec 31, 2016 | 24M | +13.6% |
| FY2015 | Dec 31, 2015 | 22M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 451M | +229.7% |
| Q2 FY2026 | Jun 30, 2026 | 434M | +222.4% |
| Q1 FY2026 | Mar 31, 2026 | 428M | +317.4% |
| Q4 FY2025 | Dec 31, 2025 | 184M | +85.2% |
| Q3 FY2025 | Sep 30, 2025 | 137M | +42.2% |
| Q2 FY2025 | Jun 30, 2025 | 134M | +39.8% |
| Q1 FY2025 | Mar 31, 2025 | 103M | +6.7% |
| Q4 FY2024 | Dec 31, 2024 | 99M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | 96M | +0.1% |
| Q2 FY2024 | Jun 30, 2024 | 96M | +2.0% |
| Q1 FY2024 | Mar 31, 2024 | 96M | +2.3% |
| Q4 FY2023 | Dec 31, 2023 | 96M | +2.0% |
| Q3 FY2023 | Sep 30, 2023 | 96M | +2.3% |
| Q2 FY2023 | Jun 30, 2023 | 94M | +42.8% |
| Q1 FY2023 | Mar 31, 2023 | 94M | +71.1% |
| Q4 FY2022 | Dec 31, 2022 | 94M | +71.5% |
| Q3 FY2022 | Sep 30, 2022 | 94M | +70.9% |
| Q2 FY2022 | Jun 30, 2022 | 66M | +20.3% |
| Q1 FY2022 | Mar 31, 2022 | 55M | +0.1% |
| Q4 FY2021 | Dec 31, 2021 | 55M | +0.2% |
| Q3 FY2021 | Sep 30, 2021 | 55M | +0.2% |
| Q2 FY2021 | Jun 30, 2021 | 55M | +0.1% |
| Q1 FY2021 | Mar 31, 2021 | 55M | +5.9% |
| Q4 FY2020 | Dec 31, 2020 | 55M | – |
| Q3 FY2020 | Sep 30, 2020 | 55M | – |
| Q2 FY2020 | Jun 30, 2020 | 55M | – |
| Q1 FY2020 | Mar 31, 2020 | 52M | – |
See a number that looks wrong?